PT-141 is a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound acts by stimulating specific receptors throughout the body, leading to augmented sexual response. Clinical studies have indicated that PT-141 could remarkably treat a variety of sexual dysfunctions in both men an